malária falciparum resistente à cloroquina e ao fansidar r tratada com minociclina minocycline treatment of chloroquine-and fansidar r-resistant falciparum malarial
Article Quality & Performance Metrics
Readership in this journal
PopularRanked #249 of 356 articles by views in proceedings - 2016 3rd international conference on information technology, computer, and electrical engineering, icitacee 2016
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 356 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
Abstract
In April 1978, a Plasmodium falciparum infection was diagnosed in an adult male in Brazilian Amazonia. The parasite was resistant in vitro to chloroquine and resistent in vivo to pyrimethamine-sulfadoxine (FansidarR). The patient was successfully treated with minocycline (MinomaxR); however, his immune response to the parasite may have played an important role in the efficacy of the minocycline treatment.
| Reference Key |
ferraroni1983revistamalria
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;José J. Ferraroni |
| Journal | proceedings - 2016 3rd international conference on information technology, computer, and electrical engineering, icitacee 2016 |
| Year | 1983 |
| DOI |
10.1590/S0034-89101983000400007
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.